Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:
“Switching 5 FU for docetaxel in the Tp-EXTREME trial results in similar OS with a better safety profile.”
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:
“Switching 5 FU for docetaxel in the Tp-EXTREME trial results in similar OS with a better safety profile.”
